ENTRY       C21357                      Compound
NAME        3-Hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-[acp];
            3-Hydroxy-4,6,8,10,12,14-hexadecahexaenoyl-[acp]
FORMULA     C16H19O2SR
REACTION    R11435 R11436
PATHWAY     map01059  Biosynthesis of enediyne antibiotics
            map01130  Biosynthesis of antibiotics
MODULE      M00824  9-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 9-membered enediyne core
            M00825  10-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 10-membered enediyne core
DBLINKS     PubChem: 319902592
ATOM        20
            1   C2b C    21.5825  -16.5078
            2   C2b C    20.3785  -17.2092
            3   C2b C    22.7924  -17.2092
            4   C2b C    19.1570  -16.5195
            5   C1c C    23.9963  -16.5078
            6   C2b C    17.9530  -17.2209
            7   C1b C    25.2178  -17.2032
            8   C2b C    16.7374  -16.5195
            9   C5a C    26.4219  -16.5019
            10  C2b C    15.5216  -17.2092
            11  S2a S    27.6375  -17.1975
            12  O5a O    26.4102  -15.0991
            13  C2b C    14.3060  -16.5078
            14  R   R    29.0344  -17.1975
            15  C2b C    13.0902  -17.2032
            16  C2b C    11.8746  -16.5019
            17  C2b C    10.6530  -17.1975
            18  C2b C     9.4432  -16.4902
            19  C1a C     8.2276  -17.1915
            20  O1a O    23.9895  -15.1201
BOND        19
            1     1   2 1
            2     1   3 2
            3     2   4 2
            4     3   5 1
            5     4   6 1
            6     5   7 1
            7     6   8 2
            8     7   9 1
            9     8  10 1
            10    9  11 1
            11    9  12 2
            12   10  13 2
            13   11  14 1
            14   13  15 1
            15   15  16 2
            16   16  17 1
            17   17  18 2
            18   18  19 1
            19    5  20 1
///
